Canada’s federal government accounts for a growing share of the unpaid debts racked up by failed cannabis companies, lending credence to claims the nation’s nascent adult-use industry is suffering from pricey fees and heavy taxation.
Matt Lamers
Matt Lamers's Latest Posts
Germany’s scaled-back cannabis law still faces EU hurdles
Germany’s cannabis ambitions could still be partially incompatible with European Union law, even though Berlin significantly scaled back the initiative, according to the country’s parliamentary research unit.
Avicanna completes marijuana unit acquisition from Shoppers Drug MartÂ
Toronto-headquartered Avicanna announced the closing of its acquisition of the Medical Cannabis by Shopper’s Business unit from major Canadian pharmacy chain Shoppers Drug Mart.
Canadian cannabis producer Cannara Biotech’s profit rises in quarter
Montreal cannabis producer Cannara Biotech reported a profit of 2.9 million Canadian dollars ($2.2 million) in its third quarter that ended in May, according to its recently released financial statements.
Canada faces ‘potential’ class action suit, ex-cannabis legalization chair says
Canada’s federal government could face legal consequences for failing to facilitate research on potential health issues experienced by cannabis smokers, according to the former chair of the task force that laid the groundwork for recreational legalization in the country.
Bedrocan owes profit to its focus on medical cannabis: Q&A with founder Tjalling Erkelens
Are medical and adult-use cannabis effectively the same thing, and can businesses thrive in both markets?
Some executives and regulators will tell you there is no real difference, but Bedrocan founder Tjalling Erkelens isn’t one of them.
Canadian producer MediPharm exports cannabis oil to US for clinical trial
Canadian marijuana producer MediPharm Labs said it completed a shipment of cannabis oil containing both CBD and THC to the United States for use in a clinical trial.
Auxly Cannabis, Imperial Brands extend maturity date of CA$123M debenture
Auxly Cannabis Group and British tobacco giant Imperial Brands agreed to extend by 24 months the maturity date of a debenture worth 123 million Canadian dollars ($94 million), to Sept. 25, 2026.
Canadian cannabis producer Tilray reports $1.4 billion annual loss
Tilray Brands on Wednesday reported a net loss of $1.4 billion (1.9 billion Canadian dollars) for its fiscal year 2023, though the Canadian cannabis producer handily beat consensus estimates in the fourth quarter.
Barbados taps GrowerIQ for marijuana industry track-and-trace
The Barbados cannabis regulator has selected Canadian technology company GrowerIQ to manage the tracking and reporting of all marijuana production on the island nation for the next five years.
Albania passes medical marijuana law
The Albanian parliament has passed a law to lay the legal and regulatory foundation for a medical and industrial cannabis industry.
Philip Morris buying Israeli cannabis firm for up to $650M, report says
Multinational tobacco giant Philip Morris International is acquiring the Israeli cannabis tech firm Syqe Medical in a deal worth up to $650 million, according to the daily Israeli business newspaper Calcalist.
